[1] |
Pediatric Pharmaceutical Committee of Chinese Pharmaceutical Association, Clinical Pharmacology Group of Chinese Medical Association of Pediatrics, Pediatric Pharmaceutical Committee of Chinese Medical Association of Pediatrics, et al.
Expert consensus on pediatric clinical application of β -lactam-β -lactamase inhibitor compounds
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(9): 641-653.
|
[2] |
Colla-borating Group of Pediatrics, Cardiovascular Imaging Speciality Committee, Chinese Research Hospital Association.
Expert consensus on risk stratification and application of cardiac magnetic resonance in children with myocarditis
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(9): 654-664.
|
[3] |
JIN Liang, ZHANG Bin.
Advances in the treatment of primary immunodeficiency diseases with atopic dermatitis-like skin manifestations
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(9): 695-700.
|
[4] |
The Subspecialty Group of Rehabilitation, the Society of Pediatrics, Chinese Medical Association.
Expert consensus on the evaluation and management of feeding disorders in clinical rehabilitation of children
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(8): 561-566.
|
[5] |
ZHENG Yi.
Standardized diagnosis and treatment of attention-deficit hyperactivity disorder
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(8): 567-570.
|
[6] |
ZHANG Xiao-hua, CUI Yong-hua, YAN Jun-juan, et al.
Evaluation and diagnosis of attention deficit hyperactivity disorder in children
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(8): 584-587.
|
[7] |
HUANG Huan-huan, HE Fan.
Common psychiatric comorbidities and treatment of atten-tion deficit hyperactivity disorder in children
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(8): 588-592.
|
[8] |
WANG Su-mei, CHEN Zi-jia.
Traditional Chinese medicine treatment for children with attention deficit hyperactivity disorder
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(8): 597-600.
|
[9] |
Academic Group of Pediatric Rheumatology and Immunology, Society of Pediatrics, Chinese Medical Doctor Association.
Consensus on diagnosis and treatment of childhood vasculitis in China: Kawasaki disease
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(7): 481-488.
|
[10] |
Academic Group of Pediatric Rheumatology and Immunology, Society of Pediatrics, Chinese Medical Doctor Association.
Consensus on diagnosis and treatment of childhood vasculitis in China:ANCA-associated vasculitis
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(7): 489-497.
|
[11] |
ZHANG Jin-man, ZHANG Yin-hong, HAN Lian-shu, et al.
Current status and tendency of neonatal genetic screening
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(7): 498-501.
|
[12] |
FANG Ying.
Emphasizing the diagnosis and treatment concept of ingestive trauma in children
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(7): 502-505.
|
[13] |
HUANG Yong-lan.
Importance of multidisciplinary diagnosis and treatment in neonatal screening
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(7): 510-513.
|
[14] |
YANG Ru-lai, SHU Qiang.
Management of positive screening and confirmed patients with neonatal genetic metabolic diseases
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(7): 513-516.
|
[15] |
WANG Xiao-hua.
Current screening, diagnosis and treatment of phenylketonuria in neonates
[J]. Chinese Journal of Practical Pediatrics, 2023, 38(7): 520-524.
|